dabigatran has been researched along with Brain Emboli in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (3.70) | 29.6817 |
| 2010's | 24 (88.89) | 24.3611 |
| 2020's | 2 (7.41) | 2.80 |
| Authors | Studies |
|---|---|
| Bladin, CF; Brueckmann, M; Chutinet, A; Cronin, L; Del Brutto, VJ; Diener, HC; Easton, JD; Estol, CJ; Granger, CB; Grauer, C; Kleine, E; Lyrer, P; Molina, CA; Sacco, RL; Schellinger, PD; Toyoda, K | 1 |
| Bar, M; Bernstein, RA; Brainin, M; Brueckmann, M; Cronin, L; Diener, HC; Donnan, G; Easton, JD; Gdovinová, Z; Granger, CB; Grauer, C; Kleine, E; Kleinig, TJ; Lyrer, P; Martins, S; Meyerhoff, J; Milling, T; Pfeilschifter, W; Poli, S; Reif, M; Rose, DZ; Sacco, RL; Šaňák, D; Schäbitz, WR | 1 |
| Ago, T; Kitazono, T; Makihara, N; Morita, T; Ohya, Y; Takaba, H; Wakisaka, K | 1 |
| Hirao, K; Kurabayashi, M; Nakamura, R; Nishimura, T; Okishige, K; Sasano, T; Shigeta, T; Yamauchi, Y | 1 |
| Bernstein, RA; Brueckmann, M; Chernyatina, M; Cotton, D; Cronin, L; Diener, HC; Donnan, G; Easton, JD; Ferro, JM; Granger, CB; Grauer, C; Grond, M; Kallmünzer, B; Kreuzer, J; Krupinski, J; Lee, BC; Lemmens, R; Masjuan, J; Odinak, M; Sacco, RL; Saver, JL; Schellinger, PD; Toni, D; Toyoda, K; Uchiyama, S | 1 |
| Ahmad, Y; Lip, GY | 1 |
| Bamimore, A; Mounsey, JP | 1 |
| Hamasaki, S; Ichiki, H; Iriki, Y; Ishida, S; Maenosono, R; Miyata, M; Namino, F; Ninomiya, Y; Oketani, N; Okui, H; Tei, C | 1 |
| Diener, HC; Weber, R | 1 |
| Hanon, O | 1 |
| Birnie, DH; Essebag, V; Healey, JS | 1 |
| Hess, T; Konturek, P | 1 |
| Cordeiro, G; Cunha, L; Duque, C; Pego, J; Sargento-Freitas, J; Silva, F | 1 |
| Brueckmann, M; Cotton, D; Cronin, L; Diener, HC; Duffy, C; Easton, JD; Granger, CB; Sacco, RL | 1 |
| Bänsch, D; Linhart, M; Nickenig, G; Schrickel, JW; Thomas, D | 1 |
| Bai, Y; Deng, H; Lip, GY; Shantsila, A | 1 |
| Thorsten, L | 1 |
| Gawaz, M; Geisler, T | 1 |
| Astell, H; Stewart, RA; White, HD; Young, L | 1 |
| Easton, JD; Johnston, SC; Kamel, H; Kim, AS | 1 |
| Masjuan, J | 2 |
| Calleja-Puerta, S | 1 |
| Lewalter, T | 1 |
| Gil Núñez, A | 1 |
| Gliem, M; Hartung, HP; Hermsen, D; Jander, S; van Rooijen, N | 1 |
| Okada, Y; Yasaka, M | 1 |
9 review(s) available for dabigatran and Brain Emboli
| Article | Year |
|---|---|
Thrombolytic Therapy in Severe Cardioembolic Stroke After Reversal of Dabigatran with Idarucizumab: Case Report and Literature Review.
Topics: Antibodies, Monoclonal, Humanized; Antithrombins; Atrial Fibrillation; Dabigatran; Humans; Intracranial Embolism; Male; Middle Aged; Stroke; Thrombolytic Therapy | 2018 |
Preventing stroke and systemic embolism in renal patients with atrial fibrillation: focus on anticoagulation.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Comorbidity; Dabigatran; Disease Management; Embolism; Female; Fibrinolytic Agents; Hemorrhage; Humans; Hypertension; Intracranial Embolism; Male; Morpholines; Patient Selection; Pyrazoles; Pyridones; Renal Insufficiency, Chronic; Risk; Risk Factors; Rivaroxaban; Severity of Illness Index; Stroke; Thiophenes; Thrombophilia; Warfarin | 2013 |
[New anticoagulants in patients with atrial fibrillation].
Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Brain Infarction; Dabigatran; Humans; Intracranial Embolism; Ischemic Attack, Transient; Morpholines; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Risk Factors; Rivaroxaban; Stroke; Thiophenes; Vitamin K | 2013 |
[Novel oral anticoagulants and atrial fibrillation in the elderly].
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Dabigatran; Drugs, Investigational; Half-Life; Humans; Intracranial Embolism; Metabolic Clearance Rate; Morpholines; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Risk Assessment; Rivaroxaban; Stroke; Thiophenes; Vitamin K | 2013 |
Management of anticoagulation around pacemaker and defibrillator surgery.
Topics: Aged; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Defibrillators, Implantable; Humans; Intracranial Embolism; Male; Pacemaker, Artificial; Warfarin | 2014 |
[Gastrointestinal bleeding under treatment with new oral anticoagulants].
Topics: Administration, Oral; Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Dabigatran; Gastrointestinal Hemorrhage; Humans; Intracranial Embolism; Morpholines; Postoperative Complications; Pyrazoles; Pyridones; Risk Factors; Rivaroxaban; Thiophenes; Thrombosis; Vitamin K; Warfarin | 2014 |
Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation: Systematic Review and Meta-Analysis.
Topics: Anticoagulants; Atrial Fibrillation; Dabigatran; Humans; Intracranial Embolism; Intracranial Thrombosis; Rivaroxaban; Stroke; Warfarin | 2017 |
[Prophylaxis of stroke and embolisms in atrial fibrillation--what is new in the guidelines?].
Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Evidence-Based Medicine; Factor Xa Inhibitors; Guideline Adherence; Hemorrhage; Humans; Intracranial Embolism; Morpholines; Randomized Controlled Trials as Topic; Risk Factors; Rivaroxaban; Stroke; Thiophenes | 2012 |
[Prevention of cardioembolic stroke].
Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Brain Ischemia; Dabigatran; Double-Blind Method; Factor Xa Inhibitors; Fibrinolytic Agents; Heart Diseases; Hemorrhage; Humans; International Normalized Ratio; Intracranial Embolism; Multicenter Studies as Topic; Prevalence; Randomized Controlled Trials as Topic; Risk Factors; Single-Blind Method; Thrombophilia; Vitamin K | 2012 |
6 trial(s) available for dabigatran and Brain Emboli
| Article | Year |
|---|---|
Predictors of Recurrent Stroke After Embolic Stroke of Undetermined Source in the RE-SPECT ESUS Trial.
Topics: Aspirin; Cerebral Infarction; Dabigatran; Embolic Stroke; Humans; Intracranial Embolism; Male; Risk Factors; Stroke; Tomography, Emission-Computed, Single-Photon | 2022 |
Antithrombotic Treatment of Embolic Stroke of Undetermined Source: RE-SPECT ESUS Elderly and Renally Impaired Subgroups.
Topics: Aged; Aged, 80 and over; Aspirin; Dabigatran; Double-Blind Method; Female; Fibrinolytic Agents; Humans; Intracranial Embolism; Kidney Diseases; Male; Middle Aged; Recurrence; Stroke | 2020 |
Clinical comparative study regarding interrupted and uninterrupted dabigatran therapy during perioperative periods of cryoballoon ablation for paroxysmal atrial fibrillation.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Brain; Catheter Ablation; Dabigatran; Drug Administration Schedule; Female; Humans; Incidence; Intracranial Embolism; Magnetic Resonance Imaging; Male; Middle Aged; Perioperative Period; Postoperative Hemorrhage; Prospective Studies; Treatment Outcome | 2019 |
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source.
Topics: Aged; Antithrombins; Aspirin; Dabigatran; Double-Blind Method; Female; Hemorrhage; Humans; Incidence; Intracranial Embolism; Kaplan-Meier Estimate; Male; Middle Aged; Platelet Aggregation Inhibitors; Recurrence; Secondary Prevention; Stroke | 2019 |
Design of Randomized, double-blind, Evaluation in secondary Stroke Prevention comparing the EfficaCy and safety of the oral Thrombin inhibitor dabigatran etexilate vs. acetylsalicylic acid in patients with Embolic Stroke of Undetermined Source (RE-SPECT E
Topics: Administration, Oral; Antithrombins; Aspirin; Dabigatran; Double-Blind Method; Fibrinolytic Agents; Humans; Intracranial Embolism; Prospective Studies; Research Design; Secondary Prevention; Stroke | 2015 |
Rationale and design of the ODIn-AF Trial: randomized evaluation of the prevention of silent cerebral thromboembolism by oral anticoagulation with dabigatran after pulmonary vein isolation for atrial fibrillation.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Catheter Ablation; Dabigatran; Hemorrhage; Humans; Intracranial Embolism; Prospective Studies; Pulmonary Veins; Research Design | 2016 |
12 other study(ies) available for dabigatran and Brain Emboli
| Article | Year |
|---|---|
RE-LYing on dabigatran for periprocedural anticoagulation: is it safe?
Topics: Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Female; Humans; Intracranial Embolism; Intracranial Thrombosis; Male; Warfarin | 2013 |
The incidence of asymptomatic cerebral microthromboembolism after atrial fibrillation ablation: comparison of warfarin and dabigatran.
Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Comorbidity; Dabigatran; Female; Humans; Incidence; Intracranial Embolism; Intracranial Thrombosis; Japan; Male; Middle Aged; Premedication; Prospective Studies; Risk Factors; Treatment Outcome; Warfarin | 2013 |
Cardioembolic stroke in a patient taking Dabigatran Etexilate: the first case report of clinical and pharmacologic resistance.
Topics: Aged; Benzimidazoles; Dabigatran; Factor Xa Inhibitors; Female; Humans; Intracranial Embolism; Pyridines; Stroke; Treatment Failure | 2014 |
[Anticoagulation in atrial fibrillation. Stroke can be prevented this way].
Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; Clinical Trials as Topic; Dabigatran; Humans; International Normalized Ratio; Intracranial Embolism; Pyridines; Stroke; Vitamin K | 2009 |
[Current and future therapies for prophylaxis of thromboembolism in atrial fibrillation].
Topics: Anticoagulants; Antithrombin Proteins; Atrial Fibrillation; Benzimidazoles; Dabigatran; Drug Therapy, Combination; Factor Xa Inhibitors; Fibrinolytic Agents; Guideline Adherence; Hemorrhage; Humans; Intracranial Embolism; Morpholines; Platelet Aggregation Inhibitors; Pyrazoles; Pyridines; Pyridones; Risk Factors; Rivaroxaban; Thiophenes; Vitamin K | 2011 |
Thrombosis on a Mechanical Aortic Valve whilst Anti-coagulated With Dabigatran.
Topics: Aortic Valve; Aortic Valve Stenosis; Benzimidazoles; beta-Alanine; Blood Coagulation; Dabigatran; Drug Resistance; Echocardiography, Transesophageal; Fibrinolytic Agents; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Humans; Intracranial Embolism; Male; Middle Aged; Postoperative Complications; Risk Adjustment; Severity of Illness Index; Thrombosis; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in patients with atrial fibrillation and prior stroke or transient ischemic attack.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cohort Studies; Cost-Benefit Analysis; Dabigatran; Databases, Factual; Dose-Response Relationship, Drug; Drug Costs; Female; Humans; Intracranial Embolism; Ischemic Attack, Transient; Male; Markov Chains; Models, Statistical; Monte Carlo Method; Quality of Life; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Stroke; Warfarin | 2012 |
[Controversy. Dabigatran in the preventive treatment of embolic stroke: arguments in favour of its utilisation as a first-choice drug].
Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Intracranial Embolism; Stroke | 2012 |
[Controversy. Dabigatran in the preventive treatment of embolic stroke: arguments against its utilisation as a first-choice drug].
Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Intracranial Embolism; Stroke | 2012 |
[Prevention of stroke in atrial fibrillation].
Topics: Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Fibrinolytic Agents; Heart Rate; Humans; International Normalized Ratio; Intracranial Embolism; Myocardial Contraction; Risk Factors; Stroke; Thrombophilia | 2012 |
Secondary intracerebral hemorrhage due to early initiation of oral anticoagulation after ischemic stroke: an experimental study in mice.
Topics: Administration, Oral; Animals; Anticoagulants; Benzimidazoles; Blood Coagulation; Brain Ischemia; Cerebral Hemorrhage; Dabigatran; Disease Models, Animal; Intracranial Embolism; Macrophages; Male; Mice; Mice, Inbred C57BL; Phenprocoumon; Pyridines; Risk Factors; Stroke; Time Factors | 2012 |
[Management of intracranial hemorrhage during anticoagulant therapy with warfarin or novel anticoagulants].
Topics: Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Dabigatran; Humans; Intracranial Embolism; Morpholines; Rivaroxaban; Thiophenes; Warfarin | 2012 |